Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Bräuer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Fortschritte Der Neurologie-Psychiatrie|April 11, 2023
[Gene Therapy for Huntington Disease]Stefan Bräuer, Björn Falkenburger
Acta Neuropathologica Communications|January 20, 2025
Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson's diseaseStefan Bräuer, Iñaki Schniewind, Elisabeth Dinter, et al.
International Journal of Molecular Sciences|May 24, 2020
Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis PatientsStefan Bräuer, René Günther, Jared Sterneckert, et al.
Journal of Parkinson'S Disease|April 7, 2026
CSF alpha-Synuclein Seed Amplification Assay results in routine clinically collected samplesElisabeth Dinter, Julia L Margraff, Iñaki Schniewind, et al.
Acta Neuropathologica Communications|October 9, 2023
Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disordersStefan Bräuer, Marcello Rossi, Johann Sajapin, et al.
Movement Disorders Clinical Practice|May 3, 2025
Speech Differences between Multiple System Atrophy and Parkinson's DiseaseTom Hähnel, Anna Nemitz, Katja Schön, et al.
European Journal of Neurology|April 16, 2025
High Agreement Across Laboratories Between Different Alpha-Synuclein Seed Amplification ProtocolsStefan Bräuer, Maximilian Weber, Christian Deuschle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 23, 2026
Alpha-synuclein quantitative seed amplification assay predicts conversion to dementiaStefan Bräuer, Verena Sondermann, Iñaki Schniewind, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Fortschritte Der Neurologie-Psychiatrie|April 11, 2023
[Gene Therapy for Huntington Disease]Stefan Bräuer, Björn Falkenburger
Acta Neuropathologica Communications|January 20, 2025
Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson's diseaseStefan Bräuer, Iñaki Schniewind, Elisabeth Dinter, et al.
International Journal of Molecular Sciences|May 24, 2020
Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis PatientsStefan Bräuer, René Günther, Jared Sterneckert, et al.
Journal of Parkinson'S Disease|April 7, 2026
CSF alpha-Synuclein Seed Amplification Assay results in routine clinically collected samplesElisabeth Dinter, Julia L Margraff, Iñaki Schniewind, et al.
Acta Neuropathologica Communications|October 9, 2023
Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disordersStefan Bräuer, Marcello Rossi, Johann Sajapin, et al.
Movement Disorders Clinical Practice|May 3, 2025
Speech Differences between Multiple System Atrophy and Parkinson's DiseaseTom Hähnel, Anna Nemitz, Katja Schön, et al.
European Journal of Neurology|April 16, 2025
High Agreement Across Laboratories Between Different Alpha-Synuclein Seed Amplification ProtocolsStefan Bräuer, Maximilian Weber, Christian Deuschle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 23, 2026
Alpha-synuclein quantitative seed amplification assay predicts conversion to dementiaStefan Bräuer, Verena Sondermann, Iñaki Schniewind, et al.
Pageof 1